P

Prime Medicine

Develops Prime Editing gene therapies

Executive Director - Supply Chain and External Manufacturing

Procurement & Sourcing +1Confirmed live in the last 24 hours
Full-timeCambridge, MA, USAIn-person

About the Job

Requirements

  • 15–20+ years of progressive experience in supply chain, technical operations, external manufacturing, process development, or Manufacturing Science and Technology (MSAT) within biotech or pharma.
  • Direct ownership of materials management and clinical supply for clinical-stage programs.
  • Experience managing contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs), including negotiating master service agreements (MSAs) and statements of work (SOWs).
  • Experience with cell therapy and/or lipid nanoparticle (LNP) or nucleic acid programs; experience supporting Investigational New Drug (IND)/Clinical Trial Application (CTA) and Biologics License Application (BLA)/Marketing Authorization Application (MAA) submissions.
  • Financial acumen, including ownership of operating budgets and multi-year cost projections.
  • Track record of implementing artificial intelligence (AI) or digital tools that improved forecasting, visibility, or decision-making in supply chain or operations, and of changing how teams work as a result.
  • Strong change management, project management, and communication skills, with the ability to build trust with partners, Finance, and senior leadership.

Responsibilities

  • Partner with the Chief Technology Officer (CTO) and Technology, Development and Operations (TDO) leadership to define manufacturing and supply chain strategy, including network design, make-versus-buy decisions, and partner selection.
  • Lead the use of AI and digital tools across supply chain and external manufacturing, including demand forecasting, materials and inventory visibility, partner performance monitoring, contract and cost modeling, and logistics tracking; keep the function current with emerging tools.
  • Own materials management across the portfolio, including forecasting, sourcing, purchasing, and inventory of raw materials, critical starting materials, and components, ensuring materials are available on time for each program.
  • Support internal planning and the manufacturing needs of each program; deliver labeling, packaging, shipping, and cell therapy logistics on time and in full; resolve supply risks before they affect timelines.
  • Build and manage a network of CDMOs, CROs, and critical suppliers, including contracts, governance, performance, and qualification of new partners.
  • Ensure supply chain documentation and external site readiness support IND and BLA submissions, working with CMC, Regulatory, Quality, Non-clinical Development, Clinical, and program teams.
  • Own TDO budget development for external spend, cost projections, and financial reporting in close partnership with functional leaders and Finance.
  • Lead, coach, and inspire supply chain and external manufacturing professionals on the team and indirect colleagues across TDO; foster accountability, continuous improvement, collaborative problem-solving, and goal attainment.

Desired Qualifications

  • A bachelor's degree in a relevant technical discipline.
  • An advanced degree (MS, MBA, or PhD).
  • Experience in a lean, fast-moving biotech environment.
  • Experience with ultra-rare diseases or small patient populations.

About the Company

Prime Medicine

Develops Prime Editing gene therapies

Prime Medicine develops gene-editing therapies designed to treat a wide range of genetic diseases. The company utilizes a specific technology called "Prime Editing," which acts like a DNA word processor. This system can search for a specific location in the genetic code and replace a faulty segment of DNA with a corrected version, restoring normal function to the gene. Unlike earlier gene-editing methods like CRISPR-Cas9, which often create double-stranded breaks in DNA that can lead to unpredictable insertions or deletions, Prime Editing makes precise changes without breaking both strands of the DNA helix. This approach allows for more control over the final genetic sequence and reduces the risk of unintended mutations. The company’s goal is to create one-time curative treatments that can halt or prevent genetic disorders, providing lifelong health benefits to patients by addressing the root cause of their conditions at the molecular level.

Company size
51-200
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2019

Recently Posted Jobs

Explore more opportunities at Prime Medicine

See more jobs